Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-01-31Clinical Trial Update: Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China
A clinical trial update examining the burden of disease among patients with myocardial infarction and dyslipidemia in China.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia [Phase 1]
A Phase 1 study evaluated the safety and tolerability of multiple doses of PF-04950615 (RN316) in adults with hypercholesterolemia. The stud…
-
FDA approval · 2018-11-20FDA Approved: ATORVASTATIN CALCIUM — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for atorvastatin calcium from Zydus Lifesciences Limited, granting generic approval for lowering chole…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes [Phase 3]
Phase 3 clinical trial update for YH14755 in adults with dyslipidemia and type II diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Study of Evacetrapib in Participants With Abnormal Cholesterol [Phase 1]
Phase 1 clinical trial update for evacetrapib in participants with dyslipidemia; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia. [Phase 2]
Phase 2 clinical trial evaluating efficacy and safety of nutraceuticals in patients with type 2 diabetes mellitus and dyslipidemia; study co…
-
FDA approval · 2018-09-10FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s original ANDA for fenofibrate, a generic lipid-lowering medication.
-
FDA approval · 2018-08-28FDA Approved: GEMFIBROZIL — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for Gemfibrozil from Zydus Lifesciences Limited, making a generic fibrate available in the United States.
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation [NA]
A completed clinical trial evaluating how dietary fatty acids affect cardiovascular risk indicators and inflammation in people with dyslipid…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators [NA]
Clinical trial update examining how dietary carbohydrate type influences cardiovascular disease risk indicators in individuals with dyslipid…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia [Phase 3]
Phase 3 clinical trial update evaluating a metformin and rosuvastatin combination in patients with type 2 diabetes mellitus and dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of the Telmisartan/Amlodipine/Rosuvastatin combination in patients with dyslipid…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Fenofibrate submitted by Bostal LLC under ANDA 207805. The approval confirms the continued appro…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: The Health Effect of Diet Rich in Nordic Berries [NA]
A completed trial examining the health effects of a diet rich in Nordic berries on metabolic syndrome, impaired glucose tolerance, dyslipide…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Effect of Pumpkin Seed Oil or Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Postmenopausal Women [NA]
This completed clinical trial assessed whether pumpkin seed oil or pumpkin seeds influence blood pressure and menopausal symptoms in postmen…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) [Phase 4]
Phase 4 ODYSSEY DM-Dyslipidemia trial comparing alirocumab added to maximally tolerated statin therapy versus usual care in patients with ty…
-
FDA approval · 2018-04-20FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS research · 2018-03-30Clinical Trial Update: Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease Risk
This clinical trial update examines adherence to European Society of Cardiology prevention guidelines in patients at high cardiovascular ris…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: The Effects of Orange Juice on Plasma Lipids [NA]
A completed clinical trial evaluating the impact of orange juice on plasma lipid levels, conducted by the University of Nottingham.
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: A Study of LY2484595 in Patients With High LDL-C or Low HDL-C [Phase 2]
A Phase 2 study of LY2484595 in patients with dyslipidemia (high LDL-C or low HDL-C) has completed, with results posted on 2018-03-22.
-
FDA approval · 2018-03-19FDA Approved: FENOFIBRATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's fenofibrate generic under an original application (ANDA). This represents the approval of a fen…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk [Phase 3]
Phase 3 update reporting cardiovascular outcomes results from Amgen's PCSK9 inhibitor program in individuals at elevated risk with dyslipide…
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial evaluating a combination therapy for hypertension and dyslipidemia; study completed.
-
FDA approval · 2018-02-01FDA Approved: NIACIN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for NIACIN, a generic niacin product intended to treat dyslipidemia and related lipid …
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: The HDL Particle Protection Study [Phase 4]
A Phase 4 clinical trial update for the HDL Particle Protection Study has completed, investigating dyslipidemia in patients with diabetes me…